Literature DB >> 12624052

Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia.

Hinda Triki1, Mohamed Ridha Barbouche, Olfa Bahri, Mohamed Bejaoui, Koussay Dellagi.   

Abstract

The global polio eradication program recommends the use of massive vaccination campaigns with live vaccine through National Immunization Days (NIDs) to displace the wild virus from the community. Immunodeficient patients may be indirectly infected and become chronic excretors and potential reservoirs of polioviruses, a concern for the posteradication era. This prospective study aimed to assess the risk of community-acquired infection of immunodeficient patients following NIDs, the dynamics of viral excretion and the genetic variation of excreted viruses. Sixteen children with various primary immunodeficiencies, who did not receive the vaccine during the campaign, were investigated. Stool samples were collected weekly, shortly after the NIDs, during at least 3 months, and were processed for viral isolation. Isolates were characterized by three intratypic differentiation methods and partial sequencing of the VP1/2A region. Polioviruses were detected in 4 out of 16 patients (serotype 1 in 3 patients and serotype 3 in 1 patient). Sequencing revealed more than 99% homology with homotypic Sabin strains, suggesting recent infection. Duration of viral excretion ranged from 1 to 7 weeks. Nine out of eleven isolates from the three poliovirus serotype 1-infected patients disclosed a non-Sabin-like phenotype by enzyme-linked immunosorbent assay and had recurrent mutations within or close to the neutralizing antigenic sites. In summary, the risk of secondary infection in immunodeficient patients is within the range previously reported for the general population. Although none of the four infected patients developed prolonged viral excretion, particular viral variants were selected and may be of epidemiological significance.

Entities:  

Mesh:

Year:  2003        PMID: 12624052      PMCID: PMC150251          DOI: 10.1128/JCM.41.3.1203-1211.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Stopping poliovirus vaccination after eradication: issues and challenges.

Authors:  D J Wood; R W Sutter; W R Dowdle
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

2.  Gaps in our knowledge about transmission of vaccine-derived polioviruses.

Authors:  P E Fine
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

Review 3.  Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies.

Authors: 
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  The final stages of the global eradication of polio.

Authors:  T J John
Journal:  N Engl J Med       Date:  2000-09-14       Impact factor: 91.245

5.  Epidemiological surveillance and control of poliomyelitis in the Republic of Cuba.

Authors:  E G Ochoa; P M Lago
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1987

6.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Outbreak of poliomyelitis--Dominican Republic and Haiti, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-12-08       Impact factor: 17.586

8.  Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.

Authors:  S O Andreasen; J E Christensen; O Marker; A R Thomsen
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

9.  Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient.

Authors:  A Bellmunt; G May; R Zell; P Pring-Akerblom; W Verhagen; A Heim
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

10.  CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.

Authors:  Z Lu; L Yuan; X Zhou; E Sotomayor; H I Levitsky; D M Pardoll
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  3 in total

Review 1.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.

Authors:  Nadia Driss; Imen Ben-Mustapha; Fethi Mellouli; Ahlem Ben Yahia; Henda Touzi; Mohamed Bejaoui; Mohamed Ben Ghorbel; Henda Triki; Mohamed-Ridha Barbouche
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

3.  Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-09-17       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.